4 free views remaining today

glycogen storage disease

ICD-10 Codes

Related ICD-10:

Description

What is Glycogen Storage Disease?

Glycogen storage diseases (GSDs) are a group of inherited genetic disorders that cause glycogen to be improperly stored in the body [7]. This can lead to various symptoms and complications, depending on the type and severity of the disease.

Types of Glycogen Storage Diseases

There are several types of GSDs, each caused by a deficiency of specific enzymes involved in glycogen metabolism. The most common types include:

  • Type I (GSDI or von Gierke disease): characterized by excessive accumulation of glycogen in the liver and kidneys [4]
  • Type II (Pompe's disease): involves abnormal amounts of glycogen in muscle tissue [10]
  • Type III: caused by deficiency of the debranching enzyme, leading to accumulation of abnormal glycogen in the liver and muscles [11]

Symptoms and Complications

The symptoms and complications of GSDs can vary depending on the type and severity of the disease. Common symptoms include:

  • Low blood sugar (hypoglycemia)
  • Enlarged liver
  • Weakness or fatigue
  • Growth abnormalities
  • Confusion or altered mental status [15]

Causes and Inheritance

GSDs are inherited genetic disorders, meaning they are passed down from parents to their children through defective genes. The inheritance pattern can be autosomal recessive, where a person must inherit two copies of the mutated gene (one from each parent) to develop the disease [13].

Treatment and Management

While there is no cure for GSDs, various treatments and management strategies can help alleviate symptoms and complications. These may include dietary modifications, enzyme replacement therapy, and other supportive care measures.

References:

[4] Description of glycogen storage disease type I (GSDI) or von Gierke disease [7] Glycogen storage diseases (GSDs) are a group of inherited genetic disorders that cause glycogen to be improperly stored in the body. [10] Glycogen storage diseases that involve skeletal muscle typically have exercise-induced symptoms, such as premature muscle fatigue, rather than fixed weakness symptoms. [11] Result: an inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen; it results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues [13] Glycogen storage disease type I (GSD I), also known as Von Gierke disease, is an inherited disorder caused by deficiencies of specific enzymes in the glycogen metabolism pathway. [15] Glycogen storage diseases are carbohydrate metabolism disorders that occur when there is a defect in the enzymes that are involved in the metabolism of glycogen, often resulting in growth abnormalities, weakness, a large liver, low blood sugar, and confusion.

Additional Characteristics

  • Glycogen storage disease
  • Inherited genetic disorder
  • Improperly stored glycogen
  • Various symptoms and complications
  • No cure but treatments and management strategies available

Signs and Symptoms

Glycogen storage disease (GSD) can manifest in various ways, depending on the type and severity of the condition. Here are some common signs and symptoms associated with GSD:

  • Low blood sugar (hypoglycemia): This is a primary symptom of GSD, particularly in infants and young children. It can cause fatigue, constant hunger, and crankiness [2][4].
  • Fatigue: People with GSD may experience persistent tiredness or weakness due to the body's inability to convert glycogen into glucose for energy [11][15].
  • Easy bruising and nosebleeds: Some individuals with GSD may exhibit easy bruising or bleeding, particularly in the nose, due to platelet dysfunction [5][7].
  • Puffy cheeks, thin chest and limbs, and swollen belly: These physical characteristics can be observed in some children with GSD, especially those with Type I (GSDI) [5][7].
  • Slow growth: Children with GSD may experience delayed or slow growth due to the body's inability to utilize glycogen for energy [10][11].
  • Muscle cramps: Some people with GSD may experience muscle cramps, particularly in the legs, due to electrolyte imbalances [6][9].
  • Irritability and crankiness: Infants and young children with GSD may exhibit irritability or crankiness due to hypoglycemia and other symptoms [2][4].

It's essential to note that these signs and symptoms can vary in severity and presentation depending on the specific type of GSD. If you suspect someone has GSD, it's crucial to consult a healthcare professional for proper diagnosis and treatment.

References: [1] Not available [2] Context 2 [3] Not available [4] Context 4 [5] Context 7 [6] Context 6 [7] Context 7 [8] Not available [9] Context 9 [10] Context 10 [11] Context 11 [12] Not available [13] Not available [14] Not available [15] Context 15

Additional Symptoms

  • Muscle cramps
  • Slow growth
  • Low blood sugar (hypoglycemia)
  • Easy bruising and nosebleeds
  • Puffy cheeks, thin chest and limbs, and swollen belly
  • fatigue
  • irritability

Diagnostic Tests

Diagnostic Tests for Glycogen Storage Disease

Glycogen storage diseases (GSDs) are a group of rare genetic disorders that affect the body's ability to store and break down glycogen, a form of sugar or glucose. Diagnosing GSD can be challenging due to its rarity and variability in symptoms. However, several diagnostic tests can help identify the condition.

Blood Tests

  • Fasting blood sugar test: This test measures blood sugar levels after an overnight fast and can indicate low blood sugar (hypoglycemia), which is a common symptom of GSD [1].
  • Blood glucose testing: Regular blood glucose monitoring can help diagnose GSD, especially in patients with hypoglycemia [2].
  • Serum creatine kinase: Elevated serum creatine kinase levels can be indicative of muscle damage, which is often seen in GSD [3].

Imaging Tests

  • MRI scan: Magnetic resonance imaging (MRI) scans can help identify liver and kidney abnormalities associated with GSD [4].
  • Biopsy: A biopsy of the affected organs, such as the liver or muscle, can provide a definitive diagnosis by examining tissue samples under a microscope [5].

Genetic Testing

  • Next-generation sequencing: This test analyzes genes associated with GSD and can identify specific mutations causing the condition [6].
  • Invitae Comprehensive Glycogen Storage Disease panel: This genetic testing panel analyzes genes associated with various GSDs, providing a comprehensive diagnosis [7].

Other Diagnostic Tests

  • Forearm ischemic test: This test measures blood lactate concentration and ammonia levels to diagnose GSD [8].
  • Liver enzymes testing: Elevated liver enzyme levels can indicate liver damage associated with GSD [9].

It's essential to note that diagnosing GSD requires a comprehensive approach, including medical history, physical examination, and various diagnostic tests. A healthcare provider may recommend multiple tests to rule out other conditions and confirm the diagnosis.

References:

[1] Context 1 [2] Context 1 [3] Context 5 [4] Context 6 [5] Context 6 [6] Context 4 [7] Context 7 [8] Context 3 [9] Context 5

Additional Diagnostic Tests

  • Imaging Tests
  • Blood Tests
  • Biopsy
  • Other Diagnostic Tests
  • Genetic Testing
  • Fasting blood sugar test
  • MRI scan
  • Serum creatine kinase
  • Next-generation sequencing
  • Invitae Comprehensive Glycogen Storage Disease panel
  • Blood glucose testing
  • Forearm ischemic test
  • Liver enzymes testing

Treatment

Treatment Options for Glycogen Storage Disease

Glycogen storage diseases (GSDs) are a group of rare genetic disorders that affect the body's ability to store and utilize glycogen, a complex carbohydrate. While there is no cure for GSD, various treatment options can help manage the condition and prevent long-term complications.

Current Treatment Options

  1. Glucagon therapy: Glucagon is used to treat GSD types V and VII by stimulating the breakdown of glycogen into glucose (1) [4].
  2. Empagliflozin: This medication has been shown to be effective in treating associated neutropenia and neutrophil dysfunction in patients with GSD type IB (3).
  3. Allopurinol: Allopurinol is used to reduce uric acid levels, which can help prevent long-term complications such as kidney stones and gout (5) [6].
  4. Gene therapy: Researchers are exploring gene therapy as a potential treatment for GSD Ia, with the goal of expressing the glucose-6-phosphatase enzyme in the liver (6).
  5. Diphenylhydantoin: This medication has been found to be effective in treating types I, III, and VI of glycogen storage diseases (7).

Management Strategies

  1. Dietary modifications: Patients with GSD may need to follow a specific diet that includes frequent meals and snacks to maintain stable blood glucose levels.
  2. Glucose or fructose intake: Oral intake of glucose or fructose can help improve exercise tolerance in patients with certain types of GSD (8).
  3. Glucagon injections: In some cases, glucagon injections may be necessary to stimulate the breakdown of glycogen into glucose.

Future Directions

Researchers are actively exploring new treatment options for GSD, including gene therapy and other innovative approaches. As our understanding of these complex disorders continues to evolve, we can expect to see improved management strategies and potentially even a cure for some forms of GSD.

References:

[1] Qi X, et al. (2024). Treatment recommendations for glycogen storage disease type IB-associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop Mol Genet Metab. 141(3):108144.

[2] Dec 1, 2022 - Glucagon is used to treat GSD types V and VII.

[3] Treatment of glycogen storage disease (5).

[4] Glycogen storage disease type I (GSD I) is a rare disease of variable clinical severity that primarily affects the liver and kidney.

[5] AAV is the most promising gene transfer vector for the treatment of glycogen storage disease type I due to its excellent safety profile, ... 4.2 Adjunct drug therapies for Glycogen storage disease type I disorders.

[6] McArdle disease (Glycogen Storage Disease type V) Cochrane Database Syst Rev. 2014; 2014. Crossref. Scopus (27).

Note: The references provided are a selection of the relevant search results and may not be an exhaustive list.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
UMLS_CUI:C0017919
oboInOwl#id
DOID:2747
core#notation
DOID:2747
IAO_0000115
A glycogen metabolism disorder that has_material_basis_in enzymes deficiencies necessary in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types.
rdf-schema#label
glycogen storage disease
oboInOwl#hasNarrowSynonym
glycogenoses
oboInOwl#hasExactSynonym
glycogenosis
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_2754
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
relatedICD
http://example.org/icd10/E74.0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2971
owl#annotatedSource
t418524

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.